Andy Trotti

Summary

Affiliation: University of South Florida
Country: USA

Publications

  1. ncbi request reprint A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
    Andy Trotti
    Radiation Oncology Program, H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 58:674-81. 2004
  2. ncbi request reprint The evolution and application of toxicity criteria
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
    Semin Radiat Oncol 12:1-3. 2002
  3. ncbi request reprint Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation
    Yuhchyau Chen
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 8647, USA
    Int J Radiat Oncol Biol Phys 64:1442-51. 2006
  4. ncbi request reprint Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI)
    A Trotti
    Division of Radiation Oncology, and the Biostatistics Core, University of South Florida, James A Haley VA Medical Center, Tampa, USA
    Int J Radiat Oncol Biol Phys 42:257-61. 1998
  5. ncbi request reprint TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
    Lancet Oncol 8:613-24. 2007
  6. ncbi request reprint CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612, USA
    Semin Radiat Oncol 13:176-81. 2003
  7. ncbi request reprint Toxicity in head and neck cancer: a review of trends and issues
    A Trotti
    Division of Radiation Oncology, H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 47:1-12. 2000
  8. ncbi request reprint Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
    A Trotti
    H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 47:13-47. 2000
  9. ncbi request reprint Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
    Andy Trotti
    Radiation Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Radiother Oncol 66:253-62. 2003
  10. ncbi request reprint Patient-reported outcomes and the evolution of adverse event reporting in oncology
    Andy Trotti
    Division of Radiation Oncology, H Lee Moffitt Cancer Center at University of South Florida, Tampa, FL 33612 9416, USA
    J Clin Oncol 25:5121-7. 2007

Detail Information

Publications26

  1. ncbi request reprint A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy
    Andy Trotti
    Radiation Oncology Program, H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 58:674-81. 2004
    ..It is hypothesized that infection plays a role in the development of OM. We tested the efficacy of iseganan HCl (iseganan), a synthetic peptide with broad-spectrum antimicrobial activity, for preventing RT-associated OM...
  2. ncbi request reprint The evolution and application of toxicity criteria
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
    Semin Radiat Oncol 12:1-3. 2002
    ..Just as the revised CTC has provided a new common standard for the grading of acute effects, a similar effort is needed in the late effects area. The creation of a unified late effects system is under active development...
  3. ncbi request reprint Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation
    Yuhchyau Chen
    Department of Radiation Oncology, James P Wilmot Cancer Center, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642 8647, USA
    Int J Radiat Oncol Biol Phys 64:1442-51. 2006
    ....
  4. ncbi request reprint Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI)
    A Trotti
    Division of Radiation Oncology, and the Biostatistics Core, University of South Florida, James A Haley VA Medical Center, Tampa, USA
    Int J Radiat Oncol Biol Phys 42:257-61. 1998
    ..The goal was to create a more complete, yet concise, head and neck site-specific module geared toward patients receiving radiation therapy for head and neck cancer...
  5. ncbi request reprint TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612 9497, USA
    Lancet Oncol 8:613-24. 2007
    ....
  6. ncbi request reprint CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment
    Andy Trotti
    H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL 33612, USA
    Semin Radiat Oncol 13:176-81. 2003
    ..This article updates recent progress in the evolution of adverse effects grading systems and reviews the development of CTCAE v3.0...
  7. ncbi request reprint Toxicity in head and neck cancer: a review of trends and issues
    A Trotti
    Division of Radiation Oncology, H Lee Moffitt Cancer Center at the University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 47:1-12. 2000
    ..Further research into the assessment and analysis of toxicity is not only crucial to improvements in quality of life (QOL), but perhaps, improved rates of disease control as well...
  8. ncbi request reprint Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy
    A Trotti
    H Lee Moffitt Cancer Center, University of South Florida, Tampa, FL, USA
    Int J Radiat Oncol Biol Phys 47:13-47. 2000
    ..CTC v. 2.0 represents an improvement in the evaluation and grading of acute toxicity for all modalities...
  9. ncbi request reprint Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review
    Andy Trotti
    Radiation Oncology Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Radiother Oncol 66:253-62. 2003
    ..To determine the frequency of mucositis and associated outcomes in patients receiving radiotherapy (RT) for head and neck cancer through a systematic review of recently published literature...
  10. ncbi request reprint Patient-reported outcomes and the evolution of adverse event reporting in oncology
    Andy Trotti
    Division of Radiation Oncology, H Lee Moffitt Cancer Center at University of South Florida, Tampa, FL 33612 9416, USA
    J Clin Oncol 25:5121-7. 2007
    ..Therefore, care must be used when developing health outcomes and safety data collection plans...
  11. ncbi request reprint Assessment of toxicity in cooperative oncology clinical trials: the long and short of it
    Clement K Gwede
    Dept of Interdisciplinary Oncology, University of South Florida and H Lee Moffitt Cancer Center and Research Institute, Tampa, USA
    J Oncol Manag 11:15-21. 2002
    ..The potential implications for toxicity data management practices, data quality, patient care management and resource utilization are discussed...
  12. ncbi request reprint Skin changes
    Gloria Wood
    Radiation Therapy, H Lee Moffitt Cancer Center, Tampa, FL, USA
    Cancer Treat Res 128:171-81. 2006
    ..Ongoing research studying acute and late skin effects works to minimize reactions and improve patient quality-of-life. However, research with strong methodology is needed to determine if any management strategy is superior...
  13. doi request reprint Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled analysis
    Tawee Tanvetyanon
    Head and Neck Program, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL 33612, USA
    Am J Otolaryngol 30:38-43. 2009
    ..Squamous cell carcinoma (SCC) is associated with IP in about 7% of cases. To date, there has been no pooled analysis to formulate a survival outcome associated with this rare condition...
  14. pmc Local excision of T2 and T3 rectal cancers after downstaging chemoradiation
    C J Kim
    Department of Surgery, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA
    Ann Surg 234:352-8; discussion 358-9. 2001
    ....
  15. ncbi request reprint The need for adverse effects reporting standards in oncology clinical trials
    Andy Trotti
    J Clin Oncol 22:19-22. 2004
  16. ncbi request reprint Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions
    Søren M Bentzen
    University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA
    Int J Radiat Oncol Biol Phys 69:S79-82. 2007
  17. ncbi request reprint Complications of radiation therapy for head and neck cancers. The patient's perspective
    Alison M Rose-Ped
    Empirica, Inc, Portland, Ore 97225, USA
    Cancer Nurs 25:461-7; quiz 468-9. 2002
    ..Trends toward more aggressive management of head and neck cancers underscore the need for new and effective therapies for oropharyngeal mucositis occurring in patients receiving radiotherapy...
  18. ncbi request reprint Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14
    K Kian Ang
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 97, Houston, TX 77030, USA
    J Clin Oncol 23:3008-15. 2005
    ..To investigate the feasibility of combining concomitant boost accelerated radiation regimen (AFX-C) with cisplatin and to assess its toxicity and the relapse pattern and survival in patients with advanced head and neck carcinoma (HNC)...
  19. ncbi request reprint P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003
    E Hammond
    LDS Hospital, Salt Lake City, UT 84143, USA
    Int J Radiat Oncol Biol Phys 57:683-92. 2003
    ..We sought to confirm this finding by analyzing patients entered on RTOG 9003, a Phase III randomized trial of altered fractionation radiotherapy...
  20. ncbi request reprint Head and neck cancer: recent advances and new standards of care
    Arlene A Forastiere
    Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Clin Oncol 24:2603-5. 2006
  21. pmc Evaluation of new treatments in radiation oncology: are they better than standard treatments?
    Heloisa P Soares
    H Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa 33612, USA
    JAMA 293:970-8. 2005
    ..To describe accurately the outcomes of innovations that are tested in randomized controlled trials (RCTs) 3 factors have to be considered: publication rate, quality of trials, and the choice of the adequate comparator intervention...
  22. ncbi request reprint Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency
    Susan E Davidson
    Department of Clinical Oncology, Christie Hospital NHS Trust, Manchester, United Kingdom
    Int J Radiat Oncol Biol Phys 69:1218-21. 2007
    ....
  23. ncbi request reprint Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer
    Arlene A Forastiere
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231 1000, USA
    N Engl J Med 349:2091-8. 2003
    ..The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown...
  24. ncbi request reprint Adverse effects: a Pandora's box for oncology
    Andy Trotti
    Int J Radiat Oncol Biol Phys 54:642-6. 2002
  25. ncbi request reprint Treatment of head and neck cancer
    Andy Trotti
    N Engl J Med 358:1076; author reply 1077-8. 2008
  26. pmc Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14)
    Adam S Garden
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:1351-5. 2008
    ..This article reports the long-term toxicity, relapse patterns, and survival in patients with advanced head and neck carcinoma...